BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7621862)

  • 1. The influence of invariant chain on the positive selection of single T cell receptor specificities.
    Tourne S; Nakano N; Viville S; Benoist C; Mathis D
    Eur J Immunol; 1995 Jul; 25(7):1851-6. PubMed ID: 7621862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities.
    Bogen B; Gleditsch L; Weiss S; Dembic Z
    Eur J Immunol; 1992 Mar; 22(3):703-9. PubMed ID: 1547816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BALB/c invariant chain mutant mice display relatively efficient maturation of CD4+ T cells in the periphery and secondary proliferative responses elicited upon peptide challenge.
    Kenty G; Bikoff EK
    J Immunol; 1999 Jul; 163(1):232-41. PubMed ID: 10384121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturation and function of mouse T-cells with a transgenic TCR positively selected by highly disparate xenogeneic porcine MHC.
    Zhao Y; Rodriguez-Barbosa JI; Zhao G; Shaffer J; Arn JS; Sykes M
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):217-28. PubMed ID: 11292257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor.
    Kaye J; Hsu ML; Sauron ME; Jameson SC; Gascoigne NR; Hedrick SM
    Nature; 1989 Oct; 341(6244):746-9. PubMed ID: 2571940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
    Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
    J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells.
    Farr A; DeRoos PC; Eastman S; Rudensky AY
    Eur J Immunol; 1996 Dec; 26(12):3185-93. PubMed ID: 8977321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice.
    Lieberman SA; Spain LM; Wang L; Berg LJ
    Cell Immunol; 1995 Apr; 162(1):56-67. PubMed ID: 7704911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-thymic selection of peripheral CD4+ T-lymphocytes on class II major histocompatibility antigen-bearing cells.
    Shen X; König R
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):87-96. PubMed ID: 11292263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of intraepithelial lymphocytes from major histocompatibility complex (MHC)-deficient mice: no evidence for a role of MHC class II antigens in the positive selection of V delta 4+ gamma delta T cells.
    Schleussner C; Ceredig R
    Eur J Immunol; 1993 Jul; 23(7):1615-22. PubMed ID: 8391987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.
    Marusić-Galesić S; Walden P
    Immunology; 1995 Jul; 85(3):442-6. PubMed ID: 7558133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and function of CD4+ T cells in mice lacking invariant chain.
    Wong P; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2133-42. PubMed ID: 8690902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymocyte antigens do not induce tolerance in the CD4+ T cell compartment.
    Jhaver KG; Chandler P; Simpson E; Mellor AL
    J Immunol; 1999 Nov; 163(9):4851-8. PubMed ID: 10528186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In the normal repertoire of CD4+ T cells, a single class II MHC/peptide complex positively selects TCRs with various antigen specificities.
    Chmielowski B; Muranski P; Ignatowicz L
    J Immunol; 1999 Jan; 162(1):95-105. PubMed ID: 9886374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of I-Ad-, but not Db-restricted peptide-induced thymic apoptosis by glucocorticoid receptor antagonist RU486 in T cell receptor transgenic mice.
    Xue Y; Murdjeva M; Okret S; McConkey D; Kiuossis D; Jondal M
    Eur J Immunol; 1996 Feb; 26(2):428-34. PubMed ID: 8617314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development.
    Yelon D; Schaefer KL; Berg LJ
    J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.